BR vs REGN · P/E 16, rev $6.89B vs P/E 14, rev $14.34B
Broadridge Financial Solutions Inc (BR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BR currently screens at market cap $17.65B and trailing P/E 16.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BR and REGN stock pages for the full models.
Not investment advice.